Partnership to harness AI for DUB-focused preclinical programmes
Alleo and Ubiquigent unite to accelerate drug discovery
Related Posts
Synendos receives EMA nod for brain therapy
Company is focused on endocannabinoid system treatments Synendos Therapeutics – a company focused on innovative endocannabinoid system (ECS) treatments – has announced that it has […]
New study reveals how brain cell communication is linked to Alzheimer’s disease
Two support cells, microglia and astrocytes, were found to communicate with each other Researchers at the Francis Crick Institute, University College London’s UK Dementia Research […]
Show time – PharmaTimes
The truth hurts. B2B healthcare advertising frequently misses the mark. As someone who leads a healthcare division at a creative agency, that’s hard for me […]